Obstructive sleep apnea and hypertrophic cardiomyopathy: A common and potential harmful combination

Sleep Medicine Reviews

Volumn 17, Issue 3, 2013, Pages 201-206

  Nerbass, Flávia B ^a   Pedrosa, Rodrigo P ^a   Danzi Soares, Naury J ^a   Drager, Luciano F ^a   Arteaga Fernández, Edmundo ^a   Lorenzi Filho, Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atrial fibrillation; Cardiovascular diseases; Hypertrophic cardiomyopathy; Obstructive sleep apnea; Sleep disordered breathing

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN;

CARDIOVASCULAR MORTALITY; CHEYNE STOKES BREATHING; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INSULIN RESISTANCE; OBESITY; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING; SUDDEN DEATH; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AORTA, THORACIC; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; OXYGEN; POLYSOMNOGRAPHY; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84875650526     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2012.06.006     Document Type: Review

References (77)

1. Maron B.J. The 2009 international hypertrophic cardiomyopathy summit. Am J Cardiol 2010, 105:1164-1168.
2. Maron B.J., Olivotto I., Bellone P., Conte M.R., Cecchi F., Flygenring B.P., et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 39:301-307.
3. Cha Y.M., Gersh B.J., Maron B.J., Boriani G., Spirito P., Hodge D.O., et al. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2007, 18:483-487.
4. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001, 104:2517-2524.
5. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
6. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of obstructive sleep apnea among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
7. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239.
8. Tufik S., Santos-Silva R., Taddei J.A., Bittencourt L.R. Obstructive sleep apnea syndrome in the São Paulo epidemiologic sleep study. Sleep Med 2010, 11:441-446.
9. Hansel B., Cohen-Aubart F., Dourmap C., Giral P., Bruckert E., Girerd X. Prevalence of sleep apnea in men with metabolic syndrome and controlled hypertension. Arch Mal Coeur Vaiss 2007, 100:637-641.
10. Drager L.F., Lopes H.F., Maki-Nunes C., Trombetta I.C., Toschi-Dias E., Alves M.J., et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010, 5:e12065.
11. Leung R.S., Bradley T.D. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001, 164:2147-2165.
12. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Circulation 2008, 118:1080-1111.
13. Drager L.F., Genta P.R., Pedrosa R.P., Nerbass F.B., Gonzaga C.C., Krieger E.M., et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010, 105:1135-1139.
14. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
15. Logan A.G., Perlikowski S.M., Mente A., Tisler A., Tkacova R., Niroumand M., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
16. Gami A.S., Pressman G., Caples S.M., Kanagala R., Gard J.J., Davison D.E., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364-367.
17. Severino S., Caso P., Cicala S., Galderisi M., de Simone L., D'Andrea A., et al. Involvement of right ventricle in left ventricular hypertrophic cardiomyopathy: analysis by pulsed Doppler tissue imaging. Eur J Echocardiogr 2000, 1:281-288.
18. Murakami K., Shigematsu Y., Hamada M., Higaki J. Insulin resistance in patients with hypertrophic cardiomyopathy. Circ J 2004, 68:650-655.
19. Ogimoto A., Shigematsu Y., Nakura J., Hara Y., Ohtsuka T., Kohara K., et al. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. J Mol Med 2005, 83:619-625.
20. Rai T.S., Dhandapany P.S., Ahluwalia T.S., Bhardwaj M., Bahl A., Talwar K.K., et al. ACE I/D polymorphism in Indian patients with hypertrophic cardiomyopathy and dilated cardiomyopathy. Mol Cell Biochem 2008, 311:67-72.
21. Kitaoka H., Kubo T., Okawa M., Yamasaki N., Matsumura Y., Nishinaga M., et al. Plasma adiponectin levels and left ventricular remodeling in hypertrophic cardiomyopathy. Int Heart J 2010, 51:51-55.
22. Force T., Bonow R.O., Houser S.R., Solaro R.J., Hershberger R.E., Adhikari B., et al. Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation 2010, 122:1130-1133.
23. Banno K., Shiomi T., Sasanabe R., Otake K., Hasegawa R., Maekawa M., et al. Sleep-disordered breathing in patients with idiopathic cardiomyopathy. Circ J 2004, 68:338-342.
24. Eleid M.F., Konecny T., Orban M., Sengupta P.P., Somers V.K., Parish J.M., et al. High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy. Am Coll Cardiol 2009, 54:1805-1809.
25. Pedrosa R.P., Drager L.F., Genta P.R., Amaro A.C., Antunes M.O., Matsumoto A.Y., et al. Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest 2010, 137:1078-1084.
26. Konecny T., Brady P.A., Orban M., Lin G., Pressman G.S., Lehar F., et al. Interactions between sleep disordered breathing and atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol 2010, 105:1597-1602.
27. Prinz C., Bitter T., Oldenburg O., Horstkotte D., Faber L. Incidence of obstructive sleep apnea in patients with hypertrophic cardiomyopathy. Congest Heart Fail 2011, 17:19-24.
28. Pedrosa R.P., Lima S.G., Drager L.F., Genta P.R., Amaro A.C., Antunes M.O., et al. Sleep quality and quality of life in patients with hypertrophic cardiomyopathy. Cardiology 2010, 117:200-206.
29. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
30. Bos J.M., Towbin J.A., Ackerman M.J. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009, 54:201-211.
31. Geske J.B., Sorajja P., Ommen S.R., Nishimura R.A. Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol 2009, 32:397-402.
32. Hoss A.J., Petterson C.H., Scherer L. Hypertrophic cardiomyopathy. Role of Doppler echocardiography in the diagnosis and therapeutic approach. Arq Bras Cardiol 1998, 70:301-306.
33. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92:785-789.
34. Maron M.S., Olivotto I., Zenovich A.G., Link M.S., Pandian N.G., Kuvin J.T., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006, 114:2232-2239.
35. Arteaga E., Ianni B.M., Fernandes F., Mady C. Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil. Am Heart J 2005, 149:1099-1105.
36. Shah P.M., Adelman A.G., Wigle E.D., Gobel F.L., Burchell H.B., Hardarson T., et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 1974, 35(Suppl. II):79-195.
37. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., Maron B.J. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995, 26:1529-1536.
38. Nistri S., Olivotto I., Betocchi S., Losi M.A., Valsecchi G., Pinamonti B., et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 2006, 98:960-965.
39. Yang H., Woo A., Monakier D., Jamorski M., Fedwick K., Wigle E.D., et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 2005, 18:1074-1082.
40. Lorenzi-Filho G., Bradley T.D. Cardiac function in sleep apnea. Sleep apnea: pathogenesis, diagnosis, and treatment 2002, 377-410. M. Dekker, New York. A.I. Pack (Ed.).
41. Parish J.M., Somers V.K. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004, 79:1036-1046.
42. Basoglu O.K., Sarac F., Sarac S., Uluer H., Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011, 6:120-125.
43. Cuhadaroĝlu C., Utkusavaş A., Oztürk L., Salman S., Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009, 187:75-81.
44. Shamsuzzaman A.S., Somers V.K. Fibrinogen, stroke, and obstructive sleep apnea: an evolving paradigm of cardiovascular risk. Am J Respir Crit Care Med 2000, 162:2018-2020.
45. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
46. Jelic S., Lederer D.J., Adams T., Padeletti M., Colombo P.C., Factor P.H., et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010, 121:1014-1021.
47. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:613-618.
48. Drager L.F., Bortolotto L.A., Figueiredo A.C., Silva B.C., Krieger E.M., Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007, 131:1379-1386.
49. Phillips C.L., Yang Q., Williams A., Roth M., Yee B.J., Hedner J.A., et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007, 16:217-225.
50. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
51. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204-210.
52. Drager L.F., Pedrosa R.P., Diniz P.M., Diegues-Silva L., Marcondes B., Couto R.B., et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011, 57:549-555.
53. Bazzano L.A., Khan Z., Reynolds K., He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
54. Haentjens P., Van Meerhaeghe A., Moscariello A., De Weerdt S., Poppe K., Dupont A., et al. Impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167:757-764.
55. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
56. Drager L.F., Bortolotto L.A., Pedrosa R.P., Krieger E.M., Lorenzi-Filho G. Left atrial diameter is independently associated with arterial stiffiness in patients with obstructive sleep apnea: potential implications for atrial fibrilation. Int J Cardiol 2010, 144:257-259.
57. Khan A., Latif F., Hawkins B., Tawk M., Sivaram C.A., Kinasewitz G. Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index. Sleep Breath 2008, 12:141-147.
58. Shivalkar B., Van de Heyning C., Kerremans M., Rinkevich D., Verbraecken J., De Backer W., et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006, 47:1433-1439.
59. Berman E.J., DiBenedetto R.J., Causey D.E., Mims T., Conneff M., Goodman L.S., et al. Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest 1991, 100:347-350.
60. Otto M.E., Belohlavek M., Romero-Corral A., Gami A.S., Gilman G., Svatikova A., et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007, 99:1298-1302.
61. Kanagala R., Murali N.S., Friedman P.A., Ammash N.M., Gersh B.J., Ballman K.V., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107:2589-2594.
62. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
63. Pedrosa R.P., Drager L.F., Antunes M.O., Arteaga E., Lorenzi-Filho G. Cheyne-stokes respiration associated with hypertrophic cardiomyopathy and normal left ventricular ejection fraction. Clinics 2010, 65:927-929.
64. Sengupta P.P., Sorajja D., Eleid M.F., Somers V.K., Ommen S.R., Parish J.M., et al. Hypertrophic obstructive cardiomyopathy and obstructive sleep apnea: an unfavorable combination. Nat Clin Pract Cardiovasc Med 2009, 6:14-15.
65. American Academy of Sleep Medicine International classification of sleep disorders, revised: diagnostic and coding manual 2001, American Academy of Sleep Medicine, Chicago.
66. Kuna S.T., Gurubhagavatula I., Maislin G., Hin S., Hartwig K.C., McCloskey S., et al. Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea. Am J Respir Crit Care Med 2011, 183:1238-1244.
67. Elias R.M., Castro M.C., de Queiroz E.L., Abensur H., Romão J.E., Lorenzi-Filho G. Obstructive sleep apnea in patients on conventional and short daily hemodialysis. Am J Nephrol 2009, 29:493-500.
68. Sin D.D., Fitzgerald F., Parker J.D., Newton G., Floras J.S., Bradley T.D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101-1106.
69. Chiu K.L., Ryan C.M., Shiota S., Ruttanaumpawan P., Arzt M., Haight J.S., et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006, 174:1378-1383.
70. Yumino D., Redolfi S., Ruttanaumpawan P., Su M.C., Smith S., Newton G.E., et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010, 121:1598-1605.
71. Elias R.M., Bradley T.D., Kasai T., Motwani S.S., Chan C.T. Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea. Nephrol Dial Transplant 2012, 27:1569-1573.
72. Redolfi S., Yumino D., Ruttanaumpawan P., Yau B., Su M.C., Lam J., et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009, 179:241-246.
73. Limbruno U., Strata G., Zucchi R., Baglini R., Mengozzi G., Balbarini A., et al. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy. Eur Heart J 1998, 19:146-153.
74. Usui K., Parker J.D., Newton G.E., Floras J.S., Ryan C.M., Bradley T.D. Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med 2006, 173:1170-1175.
75. Rossner S., Lagerstrand L., Persson H.E., Sachs C. The sleep apnoea syndrome in obesity: risk of sudden death. J Intern Med 1991, 230:135-141.
76. Maron B.J., Olivotto I., Spirito P., Casey S.A., Bellone P., Gohman T.E., et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000, 102:858-864.
77. Maron B.J. Hypertrophic cardiomyopathy. Lancet 1997, 350:127-133.